Insulin resistance and sustained virological response in hepatitis C: from bench to bedside.
Manuel
M
Romero-Gómez
D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005838:Genotype; D006305:Health Status Indicators; D016174:Hepacivirus / Q000187:drug effects* / Q000235:genetics; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy* / Q000208:ethnology / Q000503:physiopathology; D006801:Humans; D007333:Insulin Resistance; D008954:Models, Biological; D011237:Predictive Value of Tests; D012367:RNA, Viral / Q000097:blood; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D019562:Viral Load; D044465:White People
D000998:Antiviral Agents; D012367:RNA, Viral